Clinical Sales Manager (San Antonio) at Karius

San Antonio, Texas, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Healthcare, Diagnostics, BiotechnologyIndustries

Requirements

Deep knowledge and experience in the greater San Antonio to Austin metropolitan area health systems
Ability to engage key stakeholders including infectious disease physicians, lab directors, C-level executives, and other clinical leaders
Expertise in consultative sales techniques (qualifying leads, assessing needs, supporting evaluations, and closing)
Fluency in discussing the science, technology, unique merits, and value of the Karius test with clinicians of all levels

Responsibilities

Grow sales revenue and test volume in territory by establishing new business in hospitals while increasing volume in existing hospitals; introduce transformational diagnostic technology by engaging key stakeholders
Collaborate with Inside Sales, Customer Success, Medical Affairs, and Marketing to achieve territory and company goals
Develop thought leaders and early adopters for the new approach to infectious disease diagnosis
Help establish the foundation and culture of a world-class commercial organization
Build, manage, and nurture market-based/regional territory comprising hospital and health system accounts
Prioritize and segment hospital and health system accounts to maximize opportunity and growth
Present product features and benefits to key stakeholders and clinical call points using consultative sales techniques; manage early evaluations to activate initial adoption and drive increased utilization
Serve as a subject matter expert, speaking with clinicians of all levels regarding the science and technology of the Karius test and how to best leverage its capabilities

Skills

Sales

Clinical Sales

Infectious Disease

Next-Generation Sequencing

Hospital Sales

Physician Relationships

C-level Engagement

Karius

Non-invasive diagnostic tests for infections

About Karius

Karius focuses on medical diagnostics for infectious diseases, offering the Karius Test, which detects over 1,000 pathogens from a single blood sample. This non-invasive test is quick and helps clinicians treat hospitalized patients by reducing the need for multiple invasive tests that can delay treatment. The Karius Test utilizes advanced genomics and artificial intelligence to identify microbial cell-free DNA (mcfDNA) in the bloodstream, providing insights into the pathogens responsible for infections. Karius sells these diagnostic tests to healthcare providers, aiming to offer a faster and less invasive alternative to traditional methods, ultimately saving lives and reducing healthcare costs. The company employs proprietary machine learning algorithms to analyze genomic data in real time, continuously updating its reference genome databases to enhance its diagnostic capabilities.

Redwood City, CaliforniaHeadquarters

2014Year Founded

$311.3MTotal Funding

SERIES_CCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Hybrid Work Options

Risks

Competition from AlphaFold 3 could overlap with Karius's genomic insights.

Rapid AI advancements by competitors may outpace Karius's technology.

Reliance on continuous funding rounds indicates potential financial instability.

Differentiation

Karius Test detects over 1,000 pathogens from a single blood sample.

The test uses advanced genomics and AI for rapid, non-invasive diagnostics.

Karius's proprietary algorithms analyze genomic data in real time.

Upsides

Karius secured $100M to expand its test beyond 400 U.S. hospitals.

FDA Breakthrough Device Designation boosts credibility and market potential.

Growing demand for non-invasive diagnostics aligns with Karius's offerings.

Land your dream remote job 3x faster with AI

Try Jobo Free